University of Nantes
Also known as: Centre Hospitalier de NANTES | Centre Hospitalier Universitaire F-44000 Nantes | CHU de Nantes | CHU DE NANTES | CHU de Nantes FRANCE | CHU Nantes | CHU NANTES | CHU- NANTES | CHU Nantes, Centre de Soins Dentaires | CHU Nantes, France | CHU NANTES/GOELAMS | CHU Nantes - Hôpital Nord Guillaume et René Laennec | CHU Nantes, Nantes University Hospital | CHU of Nantes | CIC-FEA, CIC 1413, CHU Nantes | Clinique des Données, CIC 1413, CHU Nantes | Departement of clinical Hematology (University Hospital of Nantes) | Eugène MARQUIS Nantes | Hotel Dieu Hospital, Nantes, France | ICO NANTES | Nantes CHU | Nantes (FR), University College Hospital | Nantes Hospital | Nantes hospital, Department of Child & adolescent psychiatry, Nantes, France | Nantes UH | NANTES UH | Nantes universitary hospital | Nantes University Hospital | Nantes University Hospital Nantes | Saint Jacques Hospital in Nantes | Université de Nantes | University Hospital, CHU de NANTES | University Hospital of Nantes | University Hospital of Nantes, France
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2000Last known activity
Mar 1, 2026
Timeline
1460s
- Apr 4, 1460
University of Nantes— Founded
Drugs by trial phase (233 distinct, 218 trials)
Phase 4 (30 own, 0 via acquisition)
Phase 3 (72 own, 0 via acquisition)
Phase 2 (95 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Studied for
- Acne Vulgaris
- Acquired Immunodeficiency Syndrome
- Acute Lung Injury
- Acute Pain
- Adrenal Insufficiency
- Aggression
- Agnosia
- Alcoholism
- Amyloidosis
- Anorexia
- Anorexia Nervosa
- Aphasia, Primary Progressive
- Arterial Occlusive Diseases
- Asthma
- Atypical Hemolytic Uremic Syndrome
- Azotemia
- Back Pain
- Birth Weight
- Blindness
- Body Weight
- Bone Demineralization, Pathologic
- Bone Neoplasms
- Brain Injuries
- Brain Injuries, Traumatic
- Breast Neoplasms
- Breech Presentation
- Brugada Syndrome
- Burns
- Carcinoma
- Carcinoma, Merkel Cell
- Carcinoma, Neuroendocrine
- Carcinoma, Squamous Cell
- Cognitive Dysfunction
- Colorectal Neoplasms
- Conjunctivitis
- Coronary Artery Disease
- Delayed Graft Function
- Dementia
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diarrhea
- Digestive System Diseases
- Ductus Arteriosus, Patent
- Eclampsia
- Edema
- Emergencies
- Familial Primary Pulmonary Hypertension
- Fetal Growth Retardation
- Fibrosis
- Frontotemporal Dementia
- Ganglion Cysts
- Gastroesophageal Reflux
- Gastrointestinal Diseases
- Giant Cell Tumor of Bone
- Giant Cell Tumors
- Graft vs Host Disease
- Hematologic Diseases
- Hemiplegia
- Hemolysis
- Hemolytic-Uremic Syndrome
- Hemorrhage
- Hepatitis C
- HIV Infections
- Hutchinson's Melanotic Freckle
- Hyperkalemia
- Hyperlipidemias
- Hypertension
- Hypertrophy
- Hypertrophy, Left Ventricular
- Infections
- Insulin Resistance
- Intervertebral Disc Degeneration
- Invasive Fungal Infections
- Irritable Bowel Syndrome
- Ischemia
- Kidney Failure, Chronic
- Leber Congenital Amaurosis
- Leg Ulcer
- Lentigo
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Lymphoid
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Low Back Pain
- Lung Diseases
- Lung Diseases, Interstitial
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Mantle-Cell
- Lymphoma, Non-Hodgkin
- Macular Edema
- Medulloblastoma
- Melanoma
- Meningitis
- Multiple Myeloma
Recent trials (50)
- NCT07274254Lead sponsorPhase 3Mar 1, 2026
- NCT07267013Lead sponsorPhase 2Jan 15, 2026
- NCT07278661Lead sponsorPhase 2Jan 1, 2026
- NCT06968559Lead sponsorPhase 3Nov 7, 2025
- NCT07027033OfficialN/AJul 1, 2025
- NCT07027033Lead sponsorN/AJul 1, 2025
- NCT06892951CollaboratorPhase 1/Phase 2Jun 30, 2025
- NCT06995287Lead sponsorPhase 3Jun 1, 2025
- NCT06931704Lead sponsorPhase 2May 1, 2025
- NCT06733129Lead sponsorPhase 3Mar 10, 2025
- NCT06263816CollaboratorPhase 3Nov 15, 2024
- NCT06642844CollaboratorPhase 3Oct 30, 2024
- NCT06356922Lead sponsorPhase 1/Phase 2Oct 22, 2024
- NCT06541067Lead sponsorPhase 2Oct 15, 2024
- NCT06252870Lead sponsorPhase 2Jul 18, 2024
Details
- Founded
- Nantes, FR Apr 4, 1460
- Last known activity
- Mar 1, 2026